Question

Which of the following is NOT a Class 1C anti-arrhythmic drug:

• A. \( \text{Propafenone} \)
• B. \( \text{Mexiletine} \)
• C. \( \text{Flecainide} \)
• D. \( \text{Moricizine} \)

Hint:

Anti-arrhythmic drugs are classified into four main classes based on the Vaughan-Williams classification. Class 1 drugs (sodium channel blockers) are further divided into: 
- 1A: Moderate sodium blockade (e.g., Quinidine). 
- 1B: Weak sodium blockade (e.g., Mexiletine). 
- 1C: Strong sodium blockade (e.g., Flecainide, Propafenone).

Answer 1

The Correct Option is B

Step 1: Understanding Class 1C anti-arrhythmic drugs. Class 1C anti-arrhythmic drugs are sodium channel blockers with a strong effect on the cardiac action potential. They are used to manage arrhythmias by slowing conduction and reducing automaticity in the heart. Examples include: - \( \text{Propafenone} \), - \( \text{Flecainide} \), - \( \text{Moricizine} \). 

Step 2: Differentiating Mexiletine. Mexiletine is a Class 1B anti-arrhythmic drug, not Class 1C. Class 1B drugs have a weaker effect on the sodium channels and are used for treating ventricular arrhythmias. 

Step 3: Comparison with other options. - Option \( (A) \): Propafenone is a Class 1C drug. 
- Option \( (C) \): Flecainide is a Class 1C drug. 
- Option \( (D) \): Moricizine is also a Class 1C drug. 

Conclusion: Mexiletine, a Class 1B drug, is the correct answer for NOT being a Class 1C anti-arrhythmic.

Answer 2

The question asks which drug among the four does not belong to the Class 1C group of anti-arrhythmic drugs. Let's check where each drug is actually classified within the Vaughan Williams system.

1. Propafenone: This drug is a Class 1C sodium channel blocker, producing a strong slowing of conduction through cardiac tissue with only a small effect on the action potential's duration, the defining trait of Class 1C agents.
2. Mexiletine: This drug is classified as Class 1B, not Class 1C. Class 1B drugs bind and unbind sodium channels quickly and mainly affect tissue that is already diseased or rapidly firing, such as after a heart attack, which is a different profile from Class 1C agents.
3. Flecainide: This drug is a Class 1C sodium channel blocker, known for its strong conduction-slowing effect and use in certain supraventricular arrhythmias, fitting squarely in the Class 1C group.
4. Moricizine: This drug is also grouped with Class 1C agents due to its strong sodium channel blocking action and slow dissociation from the channel, similar to propafenone and flecainide.

Propafenone, flecainide, and moricizine all share the strong, slow-dissociating sodium channel block that defines Class 1C, while mexiletine's fast-binding, disease-tissue-selective profile places it in Class 1B instead.

So the correct answer is Mexiletine.